financetom
Business
financetom
/
Business
/
Reselling business in Europe aided Q1 revenue, says Persistent Systems
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Reselling business in Europe aided Q1 revenue, says Persistent Systems
Jul 30, 2018 3:07 AM

Reselling business in Europe aided Q1 FY19 revenue, however, there was a weakness in the services and digital verticals, said Anand Deshpande, Founder, MD and CEO, Persistent Systems.

"The business contributed $6-7 million to revenues," Deshpande said.

The Pune-based IT firm reported a good set of first-quarter earnings. The company reported a net profit of Rs 87.34 crore for the quarter ended June 30, 2018.

The quarter-on-quarter (Q-o-Q) dollar revenues were up 5.7 percent at $123.6 million against $116.95 million. The domestic revenues were up at Rs 834.28 crore against Rs 752.5 crore Q-o-Q. The services business revenues were down 1.2 percent in the quarter.

Going forward, FY19 revenue growth should be better than FY18, he said, adding that it is too early to give a guidance.

In the second quarter the EBIT margins could be impacted because of wage hikes by around 2 percent, he said.

"But it could be covered over the year because of increased revenues," Deshpande said.

Services business pipeline looks very healthy on back of investments in few products and with some of the healthcare projects should give better revenues in the next two quarters, he added.

Even the outlook for digital continues to be strong, he said, adding that there is a lot of activity around data, digital and Internet of Thing (IoT) sectors.

“Q2 will be stronger than Q1 on all the other parameters as well,” said Deshpande.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
LifeMD Names Atul Kavthekar as CFO
LifeMD Names Atul Kavthekar as CFO
Mar 16, 2026
10:27 AM EDT, 03/16/2026 (MT Newswires) -- LifeMD ( LFMD ) said Monday it has named Atul Kavthekar as its chief financial officer, effective immediately. Kavthekar is replacing Marc Benathen, who is leaving to pursue another opportunity and will remain with LifeMD ( LFMD ) through March 31 to ensure a smooth transition, the company said. LifeMD ( LFMD )...
Why Is Silvaco Group Stock Gaining Monday?
Why Is Silvaco Group Stock Gaining Monday?
Mar 16, 2026
Silvaco Group ( SVCO ) shares rose Monday as traders digested the company’s latest quarterly update and forward outlook. Earnings Snapshot The company last week reported fourth-quarter losses of three cents per share, which beat the consensus estimate of a loss of 12 cents. Also, sales of $18.25 million beat the analyst consensus estimate of $16.33 million. Walden Rhines, Silvaco’s Chief Executive Officer, said it secured...
Lightwave Logic Makes High-Speed Modulator Platform Available to Support GlobalFoundries' Silicon Photonics Platform
Lightwave Logic Makes High-Speed Modulator Platform Available to Support GlobalFoundries' Silicon Photonics Platform
Mar 16, 2026
10:27 AM EDT, 03/16/2026 (MT Newswires) -- Lightwave Logic ( LWLG ) reported Monday the availability of its high-speed modulator platform as part of the GDSFactory process design kit, which supports GlobalFoundries' ( GFS ) silicon photonics manufacturing platform. Further, GlobalFoundries ( GFS ) is optimizing its silicon photonics process flow to support advanced slot waveguide manufacturing in alignment with...
Ascendis Reports TransCon CNP Shows Durable Benefits in New Data
Ascendis Reports TransCon CNP Shows Durable Benefits in New Data
Mar 16, 2026
10:30 AM EDT, 03/16/2026 (MT Newswires) -- Ascendis Pharma ( ASND ) said Monday new data showed children with achondroplasia treated with TransCon CNP kept consistent growth improvements through week 104, with improvement in body proportionality during the second year of treatment. Two-year data from the ApproaCH Trial demonstrated continued improvement in body proportionality and sustained increases in linear growth,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved